Champlain Investment Partners LLC Has $241.94 Million Stock Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Champlain Investment Partners LLC lowered its stake in Ryan Specialty Holdings, Inc. (NYSE:RYANFree Report) by 24.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,644,250 shares of the company’s stock after selling 1,200,472 shares during the quarter. Ryan Specialty comprises approximately 1.5% of Champlain Investment Partners LLC’s investment portfolio, making the stock its 14th biggest holding. Champlain Investment Partners LLC owned 1.39% of Ryan Specialty worth $241,942,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Blair William & Co. IL raised its position in Ryan Specialty by 3.4% in the 2nd quarter. Blair William & Co. IL now owns 2,866,003 shares of the company’s stock valued at $165,970,000 after buying an additional 94,663 shares during the last quarter. Eagle Asset Management Inc. grew its stake in shares of Ryan Specialty by 32.1% during the 3rd quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock worth $98,555,000 after acquiring an additional 335,180 shares in the last quarter. Jennison Associates LLC grew its stake in shares of Ryan Specialty by 60.2% during the 3rd quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock worth $68,054,000 after acquiring an additional 385,366 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in shares of Ryan Specialty by 43.9% in the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock valued at $62,286,000 after purchasing an additional 286,380 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its position in shares of Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock worth $56,545,000 after purchasing an additional 509,548 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

Insider Transactions at Ryan Specialty

In related news, Director Nicholas Dominic Cortezi sold 2,325 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $64.60, for a total value of $150,195.00. Following the transaction, the director now directly owns 3,463 shares in the company, valued at approximately $223,709.80. This represents a 40.17 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the transaction, the executive vice president now directly owns 12,386 shares in the company, valued at approximately $884,236.54. This represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 22,490 shares of company stock worth $1,553,977. Company insiders own 11.10% of the company’s stock.

Ryan Specialty Trading Up 2.5 %

Shares of Ryan Specialty stock opened at $73.52 on Friday. Ryan Specialty Holdings, Inc. has a 1 year low of $41.49 and a 1 year high of $74.53. The company has a market capitalization of $19.25 billion, a price-to-earnings ratio of 95.48, a P/E/G ratio of 1.63 and a beta of 0.62. The business has a fifty day simple moving average of $69.06 and a two-hundred day simple moving average of $62.51. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYANGet Free Report) last announced its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting the consensus estimate of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business had revenue of $604.69 million during the quarter, compared to the consensus estimate of $602.04 million. During the same quarter in the previous year, the firm posted $0.32 EPS. Ryan Specialty’s revenue was up 20.5% compared to the same quarter last year. Research analysts forecast that Ryan Specialty Holdings, Inc. will post 1.8 EPS for the current year.

Ryan Specialty Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be given a $0.11 dividend. This represents a $0.44 annualized dividend and a dividend yield of 0.60%. The ex-dividend date is Tuesday, November 12th. Ryan Specialty’s payout ratio is 57.14%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on RYAN shares. Bank of America lifted their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. UBS Group upped their target price on Ryan Specialty from $67.00 to $76.00 and gave the stock a “buy” rating in a report on Tuesday, August 13th. BMO Capital Markets upgraded Ryan Specialty from a “market perform” rating to an “outperform” rating and raised their price target for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. The Goldman Sachs Group boosted their price target on Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 9th. Finally, JPMorgan Chase & Co. increased their price objective on Ryan Specialty from $54.00 to $56.00 and gave the company an “underweight” rating in a report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have given a buy rating to the stock. According to MarketBeat, Ryan Specialty presently has a consensus rating of “Hold” and an average target price of $71.67.

View Our Latest Stock Analysis on Ryan Specialty

About Ryan Specialty

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Further Reading

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.